So honored to receive first prize at this years PitchFest hosted by Yale Ventures. I pitched our ROS1 biologic for invasive cancer. A...

With YCBI back in-person (and pizza), Hengyi presents a RIP update revealing her breakthroughs on the signaling logic of ROS.

At today's Pharmacology RIP talk Jianan reveals her progress in understanding the complex interactions and signaling cross talk between...

At today's Yale Pharmacology Research in Progress (RiP) talk, Dr. Tongqing Li reveals her latest breakthroughs on 2 novel and unique...

Dr. Wang, a postdoctoral fellow in the Klein and Pusztai Labs, presents her work on the discovery of therapeutic antibodies to treat...

Our ALK story available on-line at Nature. The remarkable structure points to clear ways to target its inhibition, when its over...

Together they are discovering the frontier of RTK cancer biology.

Tongqing represents the Klein Lab, presenting her latest work on ALK.

The Klein Lab has received a 5 year 2 million dollar grant to study ways to inhibit Anaplastic Lymphoma Kinase – A major driver of...

Tongqing presented results from her All Points West (APW) minigrant awarded as a collaboration between the Crawford and Klein Labs. The...

Congrats to the ALK and Phage members of KeinLab@Yale! This grant will help us develop antibodies to target ALK – an important receptor...

Dr. Hengyi Li arrives after receiving her doctorate from Peking University. There she worked in Prof. Luhua Lai's group. Dr. H. Li will...

Dr. Yueyue Wang has joined the Klein Lab. Dr. Wang will be a joint Postdoctoral Fellow between The Klein Lab and Lajos Pusztai's Lab. Dr....

The KleinLab@Yale congratulates Jianan. Well done. And now the joy of discovery! #research #science

Congrats to Dr. Tongqing Li and Tyler Goddard (Crawford Lab) for winning Yale's first All Points West Grant. This award will allow them...